Rivaroxaban plus aspirin vs. dual antiplatelet therapy in endovascular treatment in peripheral artery disease and analysis of medication utilization of different lesioned vascular regions

Rivaroxaban plus aspirin vs. dual antiplatelet therapy in endovascular treatment in peripheral artery disease and analysis of medication utilization of different lesioned vascular regions

BackgroundIn the management of Peripheral Arterial Disease (PAD), the administration of anticoagulant or antiplatelet agents is imperative. The use of Dual Antiplatelet Therapy (DAPT) in conjunction with rivaroxaban has shown potential in mitigating adverse outcomes. Given the heterogeneity in the p...

Full description

Bibliographic Details
Main Authors: SiYan Huo, Jun Cheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Surgery
Subjects:
peripheral arterial disease (PAD)
under-the-knee artery disease
rivaroxaban
aspirin
endovascular treatment (EVT)
bleeding risk
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2023.1285553/full

Internet

https://www.frontiersin.org/articles/10.3389/fsurg.2023.1285553/full

Similar Items